Does RITUXIMAB Cause Product use in unapproved indication? 7,519 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 7,519 reports of Product use in unapproved indication have been filed in association with RITUXIMAB (Rituxan). This represents 4.2% of all adverse event reports for RITUXIMAB.
7,519
Reports of Product use in unapproved indication with RITUXIMAB
4.2%
of all RITUXIMAB reports
2,156
Deaths
2,831
Hospitalizations
How Dangerous Is Product use in unapproved indication From RITUXIMAB?
Of the 7,519 reports, 2,156 (28.7%) resulted in death, 2,831 (37.7%) required hospitalization, and 1,808 (24.0%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 7,519 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
CYCLOSPORINE (5,019)
Which RITUXIMAB Alternatives Have Lower Product use in unapproved indication Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE